Doximity, Inc. (NYSE: DOCS) is making a persuasive case that clinical AI can be both useful to physicians and financially disciplined enough to interest Wall Street. Its fiscal 2027 first-quarter report delivered accelerating revenue growth, resilient profitability and a sharp rise in…
